EDGAR Filing Documents for 0001213900-24-036639

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001213900-24-036639

Filing Date

2024-04-26

Accepted

2024-04-26 16:09:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFINITIVE ADDITIONAL MATERIALS	ea0204554-02.htm	DEFA14A	36439
2	GRAPHIC	tproxy_001.jpg	GRAPHIC	1492034
3	GRAPHIC	tproxy_002.jpg	GRAPHIC	1280024
	Complete submission text file	0001213900-24-036639.txt		3856181

Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010

Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337

Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36694 | Film No.: 24883730
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)